Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurotransmitter changes by interferon-alpha and therapeutic implications.

M Schaefer1, M Schwaiger, M Pich

  • 1Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Charité-Mitte (CCM), Berlin, Germany. martin.schaefer@charite.de

Pharmacopsychiatry
|December 17, 2003
PubMed
Summary

Interferon alpha (IFN-alpha) treatment can cause severe neuropsychiatric side effects. Research suggests these may stem from IFN-alpha

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline characteristics of a diagnostically defined early psychosis cohort entering supported employment and education: findings from the SEEearly trial.

European archives of psychiatry and clinical neuroscience·2026
Same author

Direct Evidence for the νd_{5/2} Orbital in ^{69}Ni: Implications for the N=40 Island of Inversion.

Physical review letters·2026
Same author

Author Correction: An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

Longitudinal characterization of inflammatory plasma protein signatures in ECT response.

Journal of affective disorders·2025
Same author

An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

[The COVID-19 pandemic in Germany: mental health trajectories, resilient and vulnerable groups].

Der Nervenarzt·2025

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Interferon alpha (IFN-alpha) is a cytokine used to treat chronic viral infections and cancers.
  • IFN-alpha therapy can lead to severe neuropsychiatric syndromes, including depression, psychosis, and confusion.
  • The underlying neurobiological mechanisms of these side effects are not well understood.

Purpose of the Study:

  • To review current research on the neurobiological effects of IFN-alpha.
  • To explore the role of neurotransmitter system modulation in IFN-alpha-associated neuropsychiatric side effects.
  • To discuss potential treatment strategies for these adverse effects.

Main Methods:

  • Literature review of recent research on IFN-alpha and neuropsychiatric effects.
  • Analysis of studies investigating neurotransmitter system changes (opioid, serotonin, dopamine, glutamate) induced by IFN-alpha.

Related Experiment Videos

  • Examination of therapeutic outcomes of antidepressants and opioid antagonists in managing IFN-alpha side effects.

    • Main Results:

    • IFN-alpha modulates key neurotransmitter systems, including serotonin, dopamine, glutamate, and opioid pathways.
    • Changes in these neurotransmitter systems are hypothesized to be central to IFN-alpha-induced neuropsychiatric complications.
    • Antidepressants (e.g., SSRIs) and opioid antagonists show potential therapeutic benefits.

    Conclusions:

    • Neurotransmitter system alterations are implicated in the pathogenesis of IFN-alpha-associated neuropsychiatric disorders.
    • Targeting these neurotransmitter systems may offer effective treatment strategies.
    • Further research is needed to fully elucidate the neurobiological underpinnings and optimize therapeutic interventions.